Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
RFP Indian Journal of Medical Psychiatry

Volume  3, Issue 1, January-June 2020, Pages 45-46
 

Case Report

A Case Report on Risperidone Induced Prolactinoma

Joann Rebekah Varghese, Ginitha Chacko, Flemin Thomas, Narayan R Mutalik, Chandrashekhar Venkaraddi Mangannavar

1,2Assistant professor, 3Research scholar, 5 Professor and HOD, Department of Clinical Pharmacy, Hanagal Shri Kumareshwar College of Pharmacy, Bagalkot-587101, Karnataka, India, 4,Professor, Department of Psychiatry, S. N. Medical College, Bagalkot-587102, Karnataka, India

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI:

Abstract

Risperidone is a second generation antipsychotic reported to cause hyperprolactinemia due to its D2 receptor antagonism, which may induce amenorrhea, altered menstrual cycle, loss of libido and increase the long-term risk of osteoporosis. However, to our knowledge, all previous reports have focused on risperidone induced hyperprolactinemia.Here we are presenting a rare case report on prolactinoma caused by risperidone.

Keywords: Risperifone; Adverse Drug reaction; prolactinoma.
 


Corresponding Author : Chandrashekhar Venkaraddi Mangannavar